Abstract Sister chromatid cohesion is regulated by cohesin complexes and topoisomerase IIα. Although relevant studies have shed some light on the relationship between these two mechanisms of cohesion during mammalian mitosis, their interplay during mammalian meiosis remains unknown. In the present study, we have studied the dynamics of topoisomerase IIα in relation to that of the cohesin subunits RAD21 and REC8, the shugoshin-like 2 (Schizosaccharomyces pombe) (SGOL2) and the polo-like kinase 1-interacting checkpoint helicase (PICH), during both male mouse meiotic divisions. Our results strikingly show that topoisomerase IIα appears at stretched strands connecting the sister kinetochores of segregating early anaphase II chromatids, once the cohesin complexes have been removed from the centromeres. Moreover, the number and length of these topoisomerase IIα-connecting strands increase between lagging chromatids at anaphase II after the chemical inhibition of the enzymatic activity of topoisomerase IIα by etoposide. Our results also show that the etoposide-induced inhibition of topoisomerase IIα is not able to rescue the loss of centromere cohesion promoted by the absence of the shugoshin SGOL2 during anaphase I. Taking into account our results, we propose a two-step model for the sequential release of centromeric cohesion during male mammalian meiosis II. We suggest that the cohesin removal is a prerequisite for the posterior topoisomerase IIα-mediated resolution of persisting catenations between segregating chromatids during anaphase II.
Introduction
Faithful chromosome segregation during mitosis and meiosis requires that sister chromatids are intimately cohered from their replication at the interphase S phase until anaphase(s). During recent years, it has become evident that sister chromatid cohesion (SCC) is maintained by cohesin protein complexes and also by DNA catenations. The ring-shaped vertebrate mitotic cohesin complex consists of four subunits: two members of the structural maintenance of chromosomes (SMCs) protein family (SMC1α and SMC3) that heterodimerise, one kleisin subunit that closes the ring (RAD21) and a HEAT repeat domain protein (SA1/ SA2) (Nasmyth 2011) . During vertebrate mitosis, the cohesin complexes are released from chromosomes in two steps. Throughout prophase, most of the cohesin complexes at chromosome arms are released by phosphorylation of the subunit SA2 by the polo-like kinase 1 (PLK1) and the participation of some cohesin regulatory proteins (Hauf et al. 2005) . Cohesin complexes at the centromere are protected from this dissociation by the complex shugoshin-like 1 (Schizosaccharomyces pombe) (SGOL1)/phosphatase PP2A (Kitajima et al. 2006; Riedel et al. 2006; Tang et al. 2006) . Once all chromosomes are accurately bioriented, and the spindle-assembly checkpoint is silenced, the few cohesin complexes remaining at chromosome arms and those present at centromeres are released by proteolytic cleavage of RAD21 by separase during the metaphase/anaphase transition (Uhlmann et al. 1999) . During meiosis, a specialised type of cell division characterised by two rounds of chromosome segregation after a single round of DNA replication to yield haploid gametes from diploid germ cells, SCC is also mediated by cohesin complexes. In mammalian meiosis, in addition to the canonical mitotic subunits SMC1α and SMC3, the kleisin RAD21 and SA1/SA2, several meiosisspecific cohesin subunits have been described. Thus, the meiotic paralogues of SMC1α and SA1/SA2 are SMC1β and STAG3, respectively, while the kleisin RAD21 has two meiosis-specific paralogues, REC8 and RAD21L Herrán et al. 2011; Ishiguro et al. 2011; Lee and Hirano 2011) . Similar to vertebrate mitosis, SCC is released in two steps during meiosis (Suja and Barbero 2009; McNicoll et al. 2013) . During mammalian meiosis I, cohesin complexes at chromosome arms are cleaved by separase during the metaphase I/ anaphase I transition to allow the segregation of recombined homologous chromosomes. In this stage, the centromeric cohesin complexes are protected against separase cleavage by the complex shugoshin SGOL2/PP2A. During meiosis II, the SGOL2/PP2A complex that was protecting centromeric cohesin complexes redistributed, depending on tension, during metaphase II, and then, the cohesin complexes are cleaved by separase to permit chromatid segregation ; Lee et al. 2008; Llano et al. 2008; Gutiérrez-Caballero et al. 2012) .
The involvement of DNA catenations in holding sister chromatids together until the onset of anaphase was proposed some time ago (Murray and Szostak 1985) . During DNA replication, sister chromatids become catenated at multiple sites. These DNA catenations are resolved by DNA topoisomerase IIα (Topo IIα), a homodimeric enzyme that introduces a transient double-strand break in one DNA molecule, passes the sister DNA molecule through the transient break and then reseals the break (Nitiss 2009a) . Topo IIα has a structural and/or enzymatic role in chromosome condensation since it is found at chromatid axes interacting with condensin complexes (Hirano 2012) , and an essential enzymatic role in DNA replication, transcription and chromosome segregation (Porter and Farr 2004; Nitiss 2009a) . It is known that Topo IIα resolves most DNA catenations along chromosome arms in interphase and early stages of mitosis to allow sister chromatid resolution (Hirano 2012) . However, DNA catenations persisting at the centromeres of metaphase chromosomes must be resolved during the metaphase/anaphase transition to allow sister chromatid segregation (Porter and Farr 2004; Lee and Bachant 2009) . Indeed, early genetic and inhibition studies in different organisms showed that in the absence or lack of function of Topo IIα, mitosis was impaired, and anaphase bridges were commonly found (Porter and Farr 2004; Lee and Bachant 2009) . More recent studies using RNAi knockdown of Topo IIα support those early observations, and in fact, Topo IIα cleavage activity at active centromeres has been demonstrated in human chromosomes (Lee and Bachant 2009) . The relevance of Topo IIα in SCC has been reinforced by the identification of the helicases PICH (Baumann et al. 2007; Spence et al. 2007; Wang et al. 2008; Ke et al. 2011; Kaulich et al. 2012) and BLM (Chan et al. 2007; Ke et al. 2011 ) at centromeric ultrafine anaphase bridges thought to contain unresolved DNA catenations in all cultured normal cells tested. Interestingly, it has also been proposed that centromere DNA decatenation by Topo IIα during early anaphase depends on previous cohesin removal (Wang et al. 2010) . In this regard, inhibition or depletion of Topo IIα rescues the cohesion defects of cohesin-depleted vertebrate cells (Vagnarelli et al. 2004; Toyoda and Yanagida 2006) .
The exact role of Topo IIα during mammalian meiotic divisions is largely unknown. Its role during mammalian meiosis has been analysed by inhibiting its function mainly with etoposide (ET). This is a potent genotoxic Topo IIα inhibitor used in cancer therapy, whose effect lies in blocking the activity of Topo IIα once it has cut the concatenated DNA molecules, but prior to the occurrence of the religation (Nitiss 2009b) . It has been reported that the ET-mediated inhibition of Topo IIα during mouse meiosis induces alterations on homologous recombination during prophase I, fragmentation of centromeric satellite DNA and failures in chromosome segregation during meiotic divisions (Kallio and Lähdetie 1996; Marchetti et al. 2001; Russell et al. 2004; Matulis and Handel 2006) . Altogether, these data suggest that Topo IIα has a role in chromosome segregation during mouse meiotic divisions, as in mitosis. However, the spatial and temporal distribution of Topo IIα during both meiotic divisions is unknown. Moreover, the exact nature of the ET-induced alterations in chromosome segregation during both mammalian meiotic divisions has not been analysed. Thus, although the regulation of cohesin removal during mammalian meiosis is relatively well studied, the decatenating role of Topo IIα is unclear at present. Thus, we need additional information on how cohesin-and Topo IIα-dependent SCC is coordinated during both mammalian meiotic divisions. On the other hand, controversial results about Topo II distribution have been previously reported in male mouse (Cobb et al. 1999) , cock (Moens and Earnshaw 1989) and Bombyx mori (Moens 1990) spermatocytes. For this and in order to address these discrepancies, a complete analysis of Topo IIα distribution in male mouse meiosis is needed.
In the present study, we first examined by immunofluorescence the subcellular distribution of Topo IIα during each stage of male mouse meiosis. We also analysed the distribution of Topo IIα with the cohesin subunits RAD21 and REC8 in order to establish their relative dynamics during both meiotic divisions. Since Topo IIα was particularly enriched at the centromere, we also studied its pattern of distribution by comparing with that of kinetochores, three important inner centromere proteins, the shugoshin SGOL2, the microtubule depolymerase mitotic centromere-associated kinesin (MCAK) and the chromosomal passenger complex protein, inner centromere protein (INCENP), and also the helicase PICH. To obtain the needed additional information concerning the role of Topo IIα during male mammalian meiosis, we inhibited its function with ET and analysed the induced alterations in chromosome segregation. Finally, we tested the behaviour of Topo IIα in a genetic mouse model of premature loss of cohesion in meiosis I (Sgol2 −/− knockout) (Llano et al. 2008 ) and, also, whether ET could rescue the defective centromere cohesion in this system. Our results lead us to propose a model that explains the temporal and spatial relationship between cohesin complexes and Topo IIα at the centromeres during the second meiotic division. We propose that there is a sequential removal of cohesin complexes followed by Topo IIα-mediated decatenation during early anaphase II.
Materials and methods

Squashing of seminiferous tubules and spreading of spermatocytes
Testes from adult male C57BL/6, Sgol2 −/− (Llano et al. 2008) and REC8-myc transgenic mice (Kudo et al. 2006) were used for this study. All animals were handled in strict accordance with good animal practice as defined by the relevant national and/or local animal welfare bodies, and all animal work was approved by the Animal Experimentation Universidad Autónoma de Madrid (UAM) Ethics Committee. Testes were removed and detunicated, and seminiferous tubules were then processed for either squashing or spreading techniques. For squashing, we followed the technique previously described (Page et al. 1998; Parra et al. 2002) . Briefly, seminiferous tubules were fixed in freshly prepared 2 % formaldehyde in phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 10.1 mM Na 2 HPO 4 , 1.7 mM KH 2 PO 4 , pH 7.4) containing 0.05 % Triton X-100 (Sigma). After 5 min, several seminiferous tubules fragments were placed on a slide coated with 1 mg/ml poly-L-lysine (Sigma) with a small drop of fixative and were gently minced with tweezers. The tubules were then squashed, and the coverslip was removed after freezing in liquid nitrogen. For the immunolabelling techniques, we proceeded as previously described (Parra et al. 2004 ). For spreading of spermatocytes, we followed the drying-down technique previously described (Peters et al. 1997 ).
Cell line and culture
Pam212 mouse cells were grown on 22-mm square glass coverslips placed into dishes, using Dulbecco's modified Eagle's medium containing 10 % (v /v ) foetal calf serum, 50 U/ml penicillin, 50 mg/ml streptomycin and 1 % (v/v) 0.2 M L -glutamine (all from Gibco). Cells were fixed in 2 % formaldehyde in PBS for 10 min and then processed for immunofluorescence.
Immunofluorescence microscopy
After fixation, the squashed or spreaded spermatocyte preparations were rinsed three times for 5 min in PBS and were incubated overnight at 4°C with the corresponding primary antibodies diluted in PBS. In double-labelling experiments, primary antibodies from different host species were incubated simultaneously. Following three washes in PBS for 5 min, the slides were incubated for 30 min at room temperature with the corresponding secondary antibodies. The slides were subsequently rinsed in PBS and counterstained for 3 min with 10 μg/ml 4′,6-diamidino-2-phenylindole (DAPI). After a final rinse in PBS, the slides were mounted with Vectashield (Vector Laboratories) and sealed with nail polish.
Immunofluorescence image stacks were collected on the Olympus BX61 Microscope equipped with epifluorescence optics, a motorised z-drive and the Olympus DP70 Digital Camera controlled by analySIS software (Soft Imaging System). Stacks were analysed and processed using the public domain ImageJ software (National Institutes of Health, USA; http://rsb.info.nih.gov/ij). Final images were processed with Adobe Photoshop 7.0 software.
Antibodies
For immunofluorescence staining, the following primary antibodies were used at the indicated dilution: mouse monoclonal 4E12 antibody against human Topo IIα (Cobb et al. 1999) at 1:10, rabbit polyclonal antibody against human Topo IIα (TopoGEN; cat. 2011-1) at 1:10, rabbit polyclonal antibody against mouse SYCP3 (Abcam; ab-15092) at 1:100, sheep polyclonal antibody against human MCAK (a gift of Linda Wordeman; Andrews et al. 2004 ) at 1:40, rabbit polyclonal antibody (pAb1186) raised against chicken INCENP which also recognises mouse INCENP (Parra et al. 2003 ) (a gift of Bill Earnshaw; Eckley et al. 1997 ) at 1:100, rabbit polyclonal antibody against the C-terminus of mouse REC8 (a gift of Jibak Lee; Lee et al. 2003) at 1:10, rabbit serum K854 against human RAD21 (Prieto et al. 2002) at 1:50, rabbit serum K1059 against mouse SGOL2 ) at 1:20, human anti-centromere autoantibody (ACA serum) revealing kinetochores (Antibodies Incorporated; 15-235) at 1:50 and rabbit antibody against human PICH (A0201) (a gift of Erich Nigg; Wang et al. 2008) at 1:5. REC8-myc was revealed with a rabbit polyclonal antibody against the myc epitope tag (Upstate; 06-549) at a 1:10 dilution.
The secondary antibodies used were as follows: donkey anti-human IgG (Jackson), donkey anti-rabbit IgG (Jackson), donkey anti-sheep (Jackson) and donkey anti-mouse IgG (Jackson). All of them were employed at a 1:150 dilution in PBS and were conjugated with either Texas Red or fluorescein isothiocyanate.
Inhibition of Topo IIα activity by etoposide
We prepared 50 mg/kg solutions of ET (Sigma-Aldrich; E1383) that correspond to 12.5 mg/ml diluted in dimethyl sulphoxide (DMSO) (Sigma-Aldrich; D5879). After tempering the drug to body temperature, we then administrated the corresponding volume of drug by intraperitoneal injections according to the mice weight. Fifteen wild-type C57BL/6 adults aged 2-3 months were used. Specimens were monitored and euthanised by cervical dislocation after 5, 24 or 48 h following all the recommendations of the Animal Experimentation UAM Ethics Committee. After conducting various tests to accurate optimal ET concentration (concentration tests for 60, 80, 100 and 200 mg/kg ET in DMSO), we concluded that the optimal ET concentration for this study was 50 mg/kg, verifying that progressively higher concentrations caused the same effects, but higher rates of cell death. No mice died after the treatment. Control tests were also performed in individuals exclusively injected with the ET solvent DMSO, to check for putative effects on meiotic divisions. Our results demonstrated that DMSO did not affect meiotic divisions. Similarly, 50 mg/kg ET was administered intraperitoneally for 24 h to Sgol2 −/− mice.
Terminal deoxynucleotidyl transferase-mediated 2′-deoxyuridine 5′-triphosphate-fluorescein nick-end labelling assay
The DNA fragmentation-associated apoptosis of ET-treated spermatocytes was detected by the TdT-mediated dUTPfluorescein nick-end labelling (TUNEL) assay by using a kit (Roche; 11684795910) according to the manufacturer's protocol. Nuclei were counterstained for 3 min with 10 μg/ml DAPI. Tests were developed on formaldehyde-fixed squashed spermatocytes of control samples and 5, 24 and 48 h after ET exposure.
Results
Topo IIα appears at the centromeres and chromatid axes during the first meiotic division
To analyse the pattern of distribution of Topo IIα during both meiotic divisions, we double-immunolocalised it with SYCP3 and with the kinetochores (ACA serum) on squashed spermatocytes ( Fig. 1) . We used the squashing technique since it does not disturb chromosome condensation and distribution in dividing spermatocytes and also allows the differentiation of all meiotic stages (Parra et al. 2002; Gómez et al. 2007 ). The labelling of SYCP3, a structural protein of the axial elements/ lateral elements (AEs/LEs) of the synaptonemal complex (SC), was used to define the meiotic staging during the first meiotic division. During prophase I, Topo IIα was detected at the chromocentres from leptonema onwards as previously reported (Cobb et al. 1999 ) (data not shown). The chromocentres that represent clustered centromere heterochromatic regions from different chromosomes and that are clearly discerned after DAPI staining are located at the nuclear periphery. However, since we projected different focal planes throughout the spermatocytes, some chromocentres appeared at the nuclear interior. In this regard, Topo IIα was located at the centromeric end of pachynema SCs as detected with the anti-SYCP3 antibody (Fig. 1a) as previously reported (Cobb et al. 1999) . Each Topo IIα-labelled chromocentre showed several kinetochore signals inside them ( Fig. 1b-d ). Staining of Topo IIα along AE/LEs of the SC was never detected. In metaphase I, when all the bivalents are bioriented, side views of the bivalents showed that SYCP3 and Topo IIα partially colocalised at the centromeres, but while SYCP3 arranged as a T-shaped signal (Parra et al. 2004 (Parra et al. , 2006 , two rounded signals of Topo IIα were observed [ Fig. 1e and Fig. S1 (a, b)]. In a more detailed analysis of topviewed centromeres, we detected that SYCP3 appeared as two closely associated rings that surrounded the two masses of Topo IIα (inserts in Fig. 1e ). In addition to the strong labelling at centromeres, Topo IIα was also detected as faint longitudinal signals along the condensed chromatids representing the chromatid axes ). In selected metaphase I bivalents, we observed that SYCP3, by contrast, was present as a series of faint and small patches at the region of contact between the sister chromatids, the so-called interchromatid domain (Prieto et al. 2001; Parra et al. 2004) [insert in Fig. 1e ; Fig (Parra et al. 2004) (Fig. 1m ) and below the kinetochore signals ( Fig. 1n-p) .
Topo IIα and cohesin occupy different subdomains at metaphase I centromeres
In order to gain insight into the centromere distribution of Topo IIα during metaphase I, we made double immunolabellings of Topo IIα with either the shugoshin SGOL2 or the microtubule depolymerase MCAK since it has been previously reported that they are markers of the inner centromere domain (Parra et al. 2006; Gómez et al. 2007; Llano et al. 2008) . Our results showed that the two round and closely associated centromere signals of Topo IIα partially colocalised with SGOL2 and MCAK ( Fig. 2a-d ) that showed a similar T-shaped distribution at the inner centromere domain. A similar result was observed when the relative distributions of Topo IIα and the cohesin subunit RAD21 (Parra et al. 2004; Gómez et al. 2007 ) were compared at metaphase I centromeres (Fig. 2e, f) . By contrast, the meiosis-specific cohesin subunit REC8 showed a commalike distribution at centromeres as previously reported ) in between the two large Topo IIα signals (Fig. 2g, h ). Additionally, Topo IIα was detected at the . e-h Metaphase I spermatocytes. Topo IIα appears at each centromere region as two large signals each one: one below each sister kinetochore and also along the chromatid axes. Note that SYCP3 is present at the inner centromere region and along the interchromatid domain. Two large and round cytoplasmic agglomerates of SYCP3 are indicated (arrowheads). Side views of selected autosomal bivalents are enlarged in e and g, and a front view of an autosomal centromere region is enlarged in e. i-l Anaphase I spermatocytes. Topo IIα is detected at the centromere regions partially colocalising with SYCP3 (i) and below the sister kinetochores (j-l) and along the chromatid axes (insert in k). m-p Telophase I spermatocytes. Topo IIα is detected at centromere regions partially colocalising with SYCP3 bars (enlargement in m) and below sister kinetochores (enlargement in o). All images are projections of different focal planes throughout the cell volume. Scale bar, 5 μm chromatid axes flanking the labelling of RAD21 (Fig. 2e, f) , REC8 (Fig. 2g, h ) and SYCP3 ( Fig. S1(a, b) ) at the interchromatid domain. These results indicate that Topo IIα and the cohesin subunits RAD21 and REC8 occupy different subdomains at the inner domain of metaphase I centromeres.
Topo IIα localises at thin strands connecting the centromeres of early anaphase II segregating chromatids During interkinesis, an interphase stage without DNA replication between the two meiotic divisions, Topo IIα was present at the large internal chromocentres that were also clearly observed after DAPI staining, where the kinetochores were found (Fig. 3a-c) . In prophase II, Topo IIα was also detected at chromocentres representing clustered centromeres of condensing chromosomes (Fig. 3d-f ). During metaphase II, when all the chromosomes were aligned at the metaphase plate, Topo IIα was detected at the centromeres. In this sense, Topo IIα appeared as one large signal below each sister kinetochore and as a strand connecting them (Fig. 3g-i, Supplementary Movie  2) . As a rule, these Topo IIα connecting strands (TOCOSs) at the inner centromeric domain were thinner than the signals Fig. 2 Relative distribution of Topo IIα, SGOL2, MCAK, RAD21 and REC8 in metaphase I bivalents. Double immunolabellings of Topo IIα (green) with either SGOL2 (red in a, b), MCAK (red in c, d), RAD21 (red in e, f) or REC8 (red in g, h) and chromatin counterstaining with DAPI (blue) on squashed metaphase I spermatocytes. Selected autosomal bivalents (arrows in a , e , g ) are enlarged for each double immunolabelling, together with their respective schematic illustrations. At each centromere, Topo IIα is detected as two large signals partially colocalising with the T-shaped labelling of SGOL2, MCAK and RAD21 at the inner centromere domain. REC8 shows a comma-like distribution in between the Topo IIα centromere signals. Note the faint and strong labelling of RAD21 and REC8 at the interchromatid domain, respectively, and the faint Topo IIα labelling at the chromatid axes (arrows in the enlargements). The centromeres of the sex chromosomes (X, Y) are indicated in a-f. All images are projections of different focal planes throughout the cell volume. Scale bar, 5 μm below each kinetochore (inserts in Fig. 3h) . Surprisingly, during early anaphase II, once chromatids had begun their migration to opposite poles, the TOCOSs persisted and appeared stretched between the separating sister kinetochores (Fig. 3j-l,  Supplementary Movie 3) . These TOCOSs were no longer observed by late anaphase II and telophase II, although Topo IIα signals were still detected below each kinetochore (Fig. 3m-o) . These observations indicate that Topo IIα provides a persisting link between the two separating centromeres during early anaphase II.
TOCOSs persist between the centromeres of early anaphase II chromatids after the release of cohesin complexes Since TOCOSs persisted in early anaphase II, and this is an unprecedented and outstanding observation, we compared their behaviour in relation to SGOL2, MCAK or the chromosomal passenger complex protein INCENP. We selected these proteins for comparative purposes because it has been reported that during chromosome congression to the metaphase II plate, these proteins redistribute from a band connecting sister kinetochores to the kinetochore region, once chromosomes have attained a bipolar orientation, and their centromeres are under tension to opposite poles (Parra et al. 2003 (Parra et al. , 2006 Gómez et al. 2007 ). Our results showed that at metaphase II, when all chromosomes are aligned and under tension, SGOL2 and MCAK signals appeared as pairs of dots at kinetochore regions (Parra et al. 2006; Gómez et al. 2007 ), while bright Topo IIα signals were apparent below them and also at TOCOSs (Fig. 4a-d) . Likewise, TOCOSs persisted during chromosome congression to the metaphase II plate, while INCENP redistributed from a band traversing the inner centromere domain (Fig. S2(a, b) ) to single signals at the kinetochore regions (Fig. S2(c, d) ) (Parra et al. 2003) .
To further define the temporal behaviour of TOCOSs in relation to cohesins, we then analysed the relative distribution of Topo IIα and the cohesin subunits RAD21 or REC8 in metaphase II and anaphase II spermatocytes (Fig. 4e-j) . As previously reported, we were not able to detect RAD21 labelling at metaphase II centromeres (Parra et al. 2004) (Fig. 4e, f) . The antibody that we used to reveal REC8 did not render any kind of signal at metaphase II centromeres in squashed spermatocytes. However, when we detected REC8 on metaphase II spermatocytes from mice expressing REC8-myc, a single REC8 signal was observed colocalising with the central region of TOCOSs (Fig. 4g, h ). Strikingly, REC8 was not detected in anaphase II spermatocytes, although stretched TOCOSs colocalised with thin chromatin threads between segregating chromatids (Fig. 4i, j) . These results suggest that the release of the cohesin REC8 from metaphase II centromeres allows the initial segregation of chromatids to opposite poles and that the putative decatenation activity of Topo IIα occurs later during early anaphase II.
Topo IIα and PICH dynamics is different during meiosis II and mitosis
Since it has been reported that the helicase PICH appears at centromeric ultrafine anaphase bridges in somatic cultured cells (Baumann et al. 2007; Spence et al. 2007; Wang et al. 2008; Ke et al. 2011; Kaulich et al. 2012) , we studied the relative distribution of PICH and Topo IIα during the metaphase II/anaphase II transition to assess whether they colocalised at TOCOSs. By using an antibody against human PICH, we were not able to detect centromere signals during the second meiotic division. However, in Pam212 mouse somatic cells, the same antibody revealed long PICH strands between the centromeres of segregating chromatids during early anaphase (Fig. S3) . Interestingly, we did not find TOCOSs in these same early anaphase cells. As during spermatogonial mitosis, Topo IIα was only detected at the centromeres and at the chromatid axes (Fig. S4) . Altogether, our data suggest that the decatenation activity of Topo IIα is differentially regulated during mitotic anaphase and meiotic anaphase II.
Inhibition of Topo IIα activity promotes chromosome lagging during meiotic divisions
We then analysed how the inhibition of Topo IIα activity with 50 mg/kg of ET could affect meiotic divisions after 5, 24 and 48 h of treatment. ET is a Topo IIα inhibitor, whose effect lies in blocking the activity of Topo IIα once it has cut the concatenated DNA molecules, but prior to the occurrence of the religation. Since it is known that ET does not disturb the chromosomal Topo IIα distribution, but only its enzymatic activity (Nitiss 2009b) , we made double immunolabellings of Topo IIα and kinetochores on treated spermatocytes to visualise putative abnormalities during meiotic divisions. The intraperitoneal administration of DMSO demonstrated that the ET solvent did not affect the progression and presence of meiotic divisions since in all metaphase I and II spermatocytes, all the bivalents/chromosomes were perfectly aligned; the percentage of univalents in metaphase I were the same as those in untreated WT spermatocytes (around 0.5 %; most of the times, the sex univalents), and we did not found anaphase bridges in anaphase I or II. Quantitative data of ET-treated spermatocytes are shown in Fig. 5 . After ET treatment, no apparent aberrations could be observed during prophase I stages after following the pairing and synapsis processes with anti-SYCP3. However, in metaphase I spermatocytes, although chromosome condensation was not affected, we found different effects on chromosome behaviour and appearance that allowed us to classify them into several categories. In this sense, we found two main categories of metaphase I spermatocytes, live with normally condensed bivalents ( Fig. S5(a) ), and dying ones with hypercompacted chromosomes that did not show immunoreactivity (Fig. S5(bf) ). In order to know whether these last degenerating metaphase I spermatocytes were undergoing apoptosis, we carried out a TUNEL assay on squashed spermatocytes. We indeed found that all these dying spermatocytes were apoptotic (Fig. S6 ), in line with previous findings showing that dividing spermatocytes showing hypercondensed chromosomes are apoptotic (Adelman and Petrini 2008) . The percentage of live metaphase I spermatocytes progressively decreased with increasing times of ET treatment and, accordingly, that of apoptotic metaphase I spermatocytes increased (Fig. 5a ). Among live metaphase I spermatocytes, we found three phenotypes: type I representing normal spermatocytes with aligned bivalents ( Fig. S5(a) ); type II that included metaphase I spermatocytes with univalents, as a rule the sex chromosomes ( Fig. 6a-d) ; and type III that comprised metaphase I spermatocytes with misaligned bivalents (data not shown). Regarding the type II phenotype, it is worth to mention that we were able to recognise univalents since they were not aligned at the metaphase I plate, and they showed kinetochores only at one of their ends. Our results showed that a prolonged ET treatment promoted a decrease in the percentage of live type I metaphase I spermatocytes, while the percentage of those of type II decreased, and the percentage of those of type III slightly increased (Fig. 5a) . Interestingly, the decrease in the percentage of live type II spermatocytes correlated with the increase in the percentage of apoptotic metaphase I spermatocytes with univalents ( Fig. 5a and Fig. S5(c, d, f) ). Likewise, the overall decrease in the percentage of type I and III live spermatocytes correlated with the increase in the percentage of apoptotic ones without univalents (Figs. 5a and Fig. S5(b, e) ). These results indicate that ET promotes misalignment of bivalents and the appearance of univalents, and that metaphase I spermatocytes with such aberrant chromosome behaviours enter into an apoptotic pathway.
In ET-treated individuals, some of the live anaphase I/ telophase I spermatocytes showed one to four lagging chromosomes with clear chromatin bridges (Fig. 5b) . Interestingly, the anaphase I/telophase I bridges were labelled with the antiTopo IIα antibody ( Fig. 6e-l; Supplementary Movie 4) . With prolonged times of ET treatment, the percentage of alive anaphase I/telophase I spermatocytes with chromatin bridges decreased, and this was concomitant with an increase in the percentage of apoptotic spermatocytes with and without bridges [Figs. 5b and Fig. S5(g, h) ].
ET also showed an effect on chromosome alignment and segregation during the second meiotic division. Thus, although most live metaphase II spermatocytes were normal (Fig. S5(k) ), a few percentage showed misaligned chromosomes . On the other hand, with a prolonged ET exposure, the percentage of apoptotic metaphase II spermatocytes increased dramatically [ Fig. 5c and Fig. S5(l-o) ]. During anaphase II/telophase II, as seen during the first division, the percentage of live spermatocytes with lagging chromosomes and chromatin bridges were relatively high at 5 h of ET treatment and then decreased with a concomitant increase in the percentage of apoptotic spermatocytes with and without bridges at 48 h [ Fig. 5d and Fig. S5(p-y) ]. One remarkable observation was that in live anaphase II/telophase II spermatocytes, the chromatin bridges that we detected were labelled with Topo IIα and also included chromatin as revealed with DAPI ( Fig. 7e-n; Supplementary Movies 5-7) . A careful inspection showed that these Topo IIα bridges connected the sister kinetochores of lagging chromatids (Fig. 7i-n) . This situation is reminiscent of the TOCOSs that stretched during normal early anaphase II spermatocytes and that finally disappeared. Taken together, these results indicate that the chemical inhibition of Topo IIα activity leads to the formation of anaphase bridges between lagging chromosomes.
Topo IIα does not maintain centromere cohesion during meiosis I in the absence of cohesin It has been previously described that in knockout mutants for the shugoshin SGOL2 cohesion disappears not only from chromosome arms but also from centromeres, during the first meiotic division. As a consequence, in metaphase II-like spermatocytes, all chromatids appear individualised (Llano et al. 2008) . In order to know whether the single chromatids found in these metaphase II-like spermatocytes are still connected by TOCOSs in the absence of centromeric cohesins, we made a double immunolabelling of Topo IIα and kinetochores on Sgol2 −/− mutant spermatocytes. Our results showed that Topo IIα appeared to be accumulated at the centromeres below the closely associated sister kinetochores in metaphase I bivalents as in normal metaphase I spermatocytes b] . In anaphase I mutant spermatocytes, although sister kinetochores had prematurely lost their association and appeared to be separated, Topo IIα was still evident below, but not between them (Fig. 8e, f) . Likewise, a centromere Topo IIα signal was evident below each kinetochore in the 40 individual chromatids found in metaphase II-like spermatocytes, and no TOCOSs were detected between those chromatids (Fig. 8i, j) . These results support that in the absence of SGOL2, the centromere cohesion mediated by cohesin complexes is lost by anaphase I/telophase I and suggest that sister catenations mediated by Topo IIα have also apparently disappeared. Next, we tried to elucidate whether the inhibition of Topo IIα by ET could rescue the loss of centromere −/− mutant spermatocytes. Our results showed that in anaphase I mutant spermatocytes, sister kinetochores were separated but not connected by TOCOSs (Fig. 8g, h ). Likewise, in treated metaphase II-like spermatocytes, all the chromatids were individualised, and TOCOSs among them were never observed, as in untreated metaphase II-like spermatocytes (Fig. 8k, l) . Altogether, these results indicate that the inhibition of Topo IIα is not able to rescue the loss of SCC in the absence of centromere cohesins during anaphase I/telophase I. 
Discussion
During vertebrate mitosis, SCC is maintained by cohesin complexes and DNA catenations. Recent data suggest that centromeric cohesin complexes are cleaved and released during the metaphase/anaphase transition and that DNA catenations at centromeres are then resolved by Topo IIα during early anaphase (Wang et al. 2010 ). However, it remains unexplored whether this phenomenon is also conserved during mammalian meiosis II. To evaluate the conservation of this phenomenon during mammalian meiosis, we have first analysed the relative pattern of distribution of Topo IIα and cohesin subunits during both meiotic divisions in male mice. We have also chemically inhibited the enzymatic activity of Topo IIα with ET to determine the nature of putative alterations in chromosome segregation. Moreover, we have also studied the behaviour of Topo IIα in the absence of centromeric cohesin complexes during meiosis II in mice knockout for the shugoshin SGOL2 and also treated with ET.
Topo IIα does not have an essential role in maintaining centromere and arm cohesion during the first meiotic division Our analysis in male mouse meiosis on squashed and spread spermatocytes demonstrates that Topo IIα is only detected at the chromocentres during prophase I, as previously reported (Cobb et al. 1999) . Hence, our data are in contrast with the other reports on cock (Moens and Earnshaw 1989) , yeast between the centromere regions of lagging homologues in anaphase I and telophase I. Note the presence of two sister kinetochores (arrowheads) at each centromere. The TOCOS detected in telophase I shows chromatin (yellow arrows). All images are projections of different focal planes throughout the cell volume. Scale bar, 3 μm (Klein et al. 1992 ) and B. mori meiocytes (Moens 1990 ), since we have never detected Topo IIα along the LEs of the SC. From prophase I onwards, there are no published data showing in detail the localisation pattern of Topo IIα in mammalian meiosis. Our results show that Topo IIα is found at the centromeres of metaphase I chromosomes as two signals below sister kinetochores and that these signals exceed laterally the signals of the inner centromere proteins shugoshin SGOL2 ) and MCAK (Parra et al. 2006) . Moreover, Topo IIα signals also exceed those of the cohesin RAD21, while the centromeric accumulation of REC8 lied in between the Topo IIα signals. Thus, Topo IIα and cohesin subunits occupy different subdomains at the inner centromere (Fig. 9) . The finding that in ET-treated metaphase I and anaphase I spermatocytes, the chromatids are still associated at their centromere regions indicates that Topo IIα has not an essential enzymatic role in maintaining centromere cohesion during the first meiotic division. Moreover, in the absence of SGOL2, centromere cohesion is lost during the anaphase I/telophase I transition (Llano et al. 2008) , and this defect is not rescued by ET-induced inhibition of Topo IIα. This result also supports that Topo IIα has no a role in the maintenance of centromere cohesion. Our results indicate that the cohesin complexes are the essential executors for maintaining centromere cohesion and that Topo IIα might have a structural role at the heterochromatic centromere regions in maintaining their topology during meiosis I. Likewise, the presence of Topo IIα along the chromatid axes of metaphase I bivalents and not at the interchromatid domain where the cohesin subunits RAD21 and REC8 are located indicate that Topo IIα is not directly involved in maintaining arm cohesion during meiosis I. Our observation that Topo IIα is still present at the chromatid axes in anaphase I chromosomes, when arm cohesion has disappeared, also supports this conclusion.
Topo IIα role in meiotic recombination and chromosome segregation during the first meiotic division
Our results show that the inhibition of Topo IIα by ET induces the appearance of univalents and misaligned bivalents in metaphase I spermatocytes that mostly enter into an apoptotic pathway with increasing times of ET treatment. The presence of univalents in these ET-treated metaphase I spermatocytes suggests that Topo IIα may have a role in regulating some aspect of meiotic recombination during prophase I. As a rule, most of the metaphase I univalents found after ET treatment are the X and Y sex chromosomes. Since sex chromosomes are under different regulation compared to autosomes in terms of condensation, gene silencing, histone modification and synapsis events, perhaps, the regulation of recombination events within the sex pair is differentially regulated, by instance, by Topo IIα. We additionally observed that in ET-treated individuals, anaphase I/telophase I spermatocytes showed a high incidence of lagging chromosomes, a predominant phenotype in anaphase when Topo IIα function is deficient during mitosis (Porter and Farr 2004) . Interestingly, we found that lagging chromosomes were connected by Topo IIα-labelled chromatin bridges that as a rule, appeared to be close to the centromeres. Since we are proposing that Topo IIα does not have a role in SCC, the presence of chromatin bridges between lagging chromosomes during anaphase I indicates that ET could induce DNA damage that would impair an accurate chromosome segregation during anaphase I (Kallio and Lähdetie 1996; Marchetti et al. 2001) . The increase in the percentage of apoptotic anaphase I/telophase I spermatocytes with increasing times of ET treatment indicates that most of the spermatocytes with lagging chromosomes enter into an apoptotic pathway. Altogether, our data suggest that Topo IIα has a role in chromosome segregation during mouse meiosis I.
Topo IIα decatenation at centromeres after removal of cohesin complexes during meiosis II One of the most outstanding results obtained in the present study refers to the appearance of TOCOSs between the sister kinetochores at the inner domain of metaphase II centromeres. This previously unknown pattern of distribution of Topo IIα at TOCOSs is reminiscent of the dense strands connecting sister kinetochores observed by electron microscopy with the Os-PPD cytochemical technique at mouse metaphase II centromeres (Parra et al. 2006) . Moreover, similar connecting strands have been observed by electron microscopy at metaphase II centromeres in the field vole Microtus agrestis (Wolf et al. 1988) . Thus, Topo IIα seems to be one of the protein components at these structural connecting strands at the inner domain of male mammalian metaphase II centromeres. In light of sex-specific differences in mammalian meiotic progression and control, our conclusions should be clearly anchored in the context of spermatogenesis and should be corroborated in females. We have found that TOCOSs persist at the inner centromere domain of aligned metaphase II chromosomes after the redistribution of SGOL2, MCAK and INCENP. In this regard, it has been reported that SGOL2, MCAK and INCENP appear as a connecting strand at the inner centromere domain of male mouse prometaphase II chromosomes but redistribute below sister kinetochores at metaphase II centromeres concomitantly with changes in tension across them (Parra et al. 2003 (Parra et al. , 2006 Gómez et al. 2007 ). Consequently, TOCOSs resist changes in tension across the centromeres during chromosome congression at the metaphase II plate.
Strikingly, we have observed that once TOCOSs are stretched, chromatids have begun their segregation to opposite poles at early anaphase II. The analysis of the relative distribution of Topo IIα and the cohesin REC8 during meiosis II showed that both proteins colocalised only at the central region of TOCOSs at the inner centromere domain of metaphase II chromosomes. Then, REC8 disappeared from the inner domain during the metaphase II/anaphase II transition, whereas TOCOSs stretched between the early anaphase II chromatids. These results support the hypothesis that the cleavage of the centromeric cohesin complexes by separase triggers the initial separation of the chromatids that still remain associated by TOCOSs (Fig. 9) . Accordingly, TOCOSs could represent the last resistance force counteracting the spindle pulling forces acting on both sister kinetochores after the release of cohesin complexes. However, this possibility seems unlikely since it has been demonstrated that in the absence of cohesin, Topo IIα cannot resist spindle pulling forces during mitosis (Oliveira et al. 2010 ) and female mouse meiosis (Tachibana-Konwalski et al. 2010) . The subsequent disappearance of TOCOSs during anaphase II suggests that Topo IIα finally decatenates the (arrowheads) of lagging chromatids in anaphase II and telophase II (e-n). Note that these TOCOSs colocalise with very thin chromatin threads between the body of both lagging chromatids (yellow arrow in k) or between the kinetochore and the body of the chromatids (purple arrows in k, n). All images are projections of different focal planes throughout the cell volume. Scale bar, 3 μm persisting centromeric connections between segregating chromatids. This last assumption is supported by our cytological observation of stretched TOCOSs between the kinetochores of lagging segregating chromatids during anaphase II after the ETmediated inhibition of the enzymatic activity of Topo IIα. In this context, we assume that Topo IIα has a catalytic activity at the centromeres during the metaphase II/anaphase II transition that promotes the decatenation of hairpin structures formed by satellite centromeric DNA, as previously demonstrated during mitosis (Floridia et al. 2000; Spence et al. 2002; Jonstrup et al. 2008) . Altogether, these data indicate that the cleavage of centromeric cohesin complexes is followed by the subsequent decatenating activity of Topo IIα during early anaphase II. A similar conclusion has been raised in vertebrate mitotic cells. In this sense, the depletion of the cohesin subunit RAD21 or the shugoshin SGOL1 promotes a premature loss of cohesion, but the simultaneous chemical inhibition or depletion of Topo IIα inhibits the release of cohesion (Vagnarelli et al. 2004; Toyoda and Yanagida 2006; Wang et al. 2010) . Accordingly, it has been proposed that during mammalian mitosis, the centromere DNA decatenation by Topo IIα depends on the previous removal of cohesin complexes (Wang et al. 2010) . A recent study developed on budding yeast circular minichromosomes also reveals that the presence of cohesin complexes retards Topo II-driven decatenation. Therefore, it is claimed that cohesin complexes regulate cohesion "directly" by embracing sister DNAs inside its rings and "indirectly" by maintaining catenations that would be only resolved by Topo II once cohesin complexes are removed from chromosomes by a separase-mediated mechanism (Farcas et al. 2011) .
It has been reported that the helicase PICH appears at centromeric ultrafine anaphase bridges thought to contain unresolved DNA catenations in all cultured cells tested (Baumann et al. 2007; Spence et al. 2007; Wang et al. 2008 ; Ke et al. 2011; Kaulich et al. 2012) . We tested the presence of PICH at the TOCOSs found during early anaphase II, but we did not detect its presence on squashed mouse spermatocytes. Conversely, we detected PICH at ultrafine anaphase bridges in Pam212 mouse somatic cells, but not the presence of Topo IIα at such bridges, but only at the centromeres. These results correlate with previous data obtained in HeLa cells where PICH anaphase bridges did not colocalise with Topo IIα (Baumann et al. 2007 ). We therefore suggest that the decatenation activity of Topo IIα is differentially regulated during mitotic anaphase and meiotic anaphase II. In this context, it is worth noting that since in metaphase II chromosomes the chromatid arms are separated, since arm cohesion was lost by anaphase I, the centromere is the only region that resists the pulling forces acting on sister kinetochores. By contrast, in mitotic metaphase chromosomes, sister chromatids remain tightly associated not only at centromeres but also along their arms. Consequently, the pulling forces on sister kinetochores are Fig. 9 Model reflecting the distribution of Topo IIα in pachynema and metaphase I and the removal of cohesin complexes and the Topo IIα-decatenating activity during the second meiotic division. Kinetochore microtubules are indicated in turquoise; kinetochores, in red; Topo IIα, in green; shugoshin SGOL2, in pink; and the cohesin subunit REC8, in blue. The colocalisation of REC8 and SGOL2 is shown in light blue. One chromosome of each bivalent is depicted in light grey, and its homologue is darker grey. Chromosomes are telocentric, and the metaphase I bivalent shows a single interstitial chiasma. In pachynema, Topo IIα decorates the chromocentres, while REC8 is located along the cohesin axes beneath the LEs of the SC of the autosomal bivalents and the AEs in the sex bivalent XY. Note that to simplify, not all the 19 autosomal bivalents are represented. In metaphase I, Topo IIα localises at two rounded accumulations below the closely associated sister kinetochores and partially colocalises with the middle region of the T-shaped SGOL2 structure at each centromere. Topo IIα is also located along the chromatid axes. REC8-containing cohesin complexes are also depicted as patches at the interchromatid domain. A hypothetical model accounting for the distribution of Topo IIα and REC8-containing cohesin complexes in relation to radial chromatin loops in a mouse metaphase I bivalent is shown. The longitudinal and transverse sections of the arms correspond to areas indicated in the metaphase I bivalent represented. During the prometaphase II/metaphase II transition, SGOL2 redistributes unmasking centromeric REC8-containing cohesin complexes. During the metaphase II/anaphase II transition, the centromeric cohesin complexes are cleaved by separase before the Topo IIα-decatenating activity at TOCOSs occurs counteracted by centromere and arm cohesion in metaphase mitotic chromosomes, but only by centromere cohesion in metaphase II chromosomes. These differences could explain two distinct ways of regulation of Topo IIα-based decatenation at mitotic and meiosis II centromeres.
In summary, taking into account previous and present results on the behaviour of the shugoshin SGOL2, the cohesin REC8 and Topo IIα, we propose a two-step model for the sequential release of centromeric cohesion during male mammalian meiosis II (Fig. 9) . According to this model, the capture of microtubules emanating from opposite poles during prometaphase II creates tension across the centromeres or at both sister kinetochores that would promote the redistribution of the cohesin protector protein SGOL2 Lee et al. 2008) . After the tension-dependent redistribution of SGOL2, the centromeric cohesin complexes would be accessible to the cleavage action of separase. This cleavage would trigger the entry into anaphase II, and the chromatids would initiate their segregation to opposite poles. Finally, the removal of cohesin complexes would allow Topo IIα to decatenate the persisting centromeric catenations. Further studies are needed to be performed to clarify the regulation of the decatenating activity of Topo IIα during meiosis II, through its phosphorylation and SUMOylation, and the participation of helicases.
